ASN Kidney Week 2024 – Glomerular Diseases: 2024 Update

ASN Kidney Week 2024 – Glomerular Diseases: 2024 Update

ASN Kidney Week 2024 Glomerular Diseases study materials support independent review of the listed nephrology program.

This is a file-based study listing, not event registration or an ASN account. The schedule below describes the original program; meals, breaks, live faculty interaction, CME and MOC are not included.

• • • Glomerular Diseases: 2024 Update

    • Glomerular Diseases: 2024 Update

      Location: Ballroom 20D, Convention Center

      Session Description

       

    • Glomerular medicine is exploding with exciting new understanding of disease pathogenesis, which has led to developments in novel genetic and serological diagnostic tools, clinical trials, and potential treatments.
    • This program explores novel changes in IgAN/Henoch-Schonlein purpura, lupus nephritis, podocytopathies (FSGS/minimal change disease), membranous GN, atypical hemolytic uremic syndrome/C3 glomerulopathy, diabetic kidney disease, glomerular disease as “CKD,” and monoclonal gammopathy of renal significance. Hot topics are reviewed, including how and when to use genetics in the diagnosis and treatment of glomerular diseases, chimeric antigen receptor T cell therapy, balancing cost and efficacy of new medications for glomerular diseases, and precision medicine and clinical trials. Experts present cutting-edge clinical applications in treatment, pathology, and genetics that continue to change the diagnostic and therapeutic landscape in glomerular diseases.
      

      Session Objectives

      Upon completion of this program, the participant will be able to: 1) describe the pathophysiology, pathology, diagnostics, and therapeutic options for glomerular diseases; 2) summarize information from current basic and clinical research studies and apply to the diagnosis and management of glomerular diseases; 3) analyze nuances in the treatment of patients with difficult-to-manage glomerular diseases; and 4) discuss when to use novel medications and/or to enroll patients in clinical trials as medical therapy options.

• Learning Pathway(s)

  • Glomerular Diseases

  Moderators

  • Sharon G. Adler, MD, FASN
  • John Cijiang He, MD, PhD, FASN

  Presentations

  • Check In and Continental Breakfast
    07:00 AM PDT – 08:00 AM PDT
    
  • Welcome and Introduction
    08:00 AM PDT – 08:10 AM PDT
    
  • Treating IgAN and IgA Vasculitis
    08:10 AM PDT – 08:45 AM PDT
    
    • Heather N. Reich, MD, PhD
  • Treating Lupus Nephritis in a New Era
    08:45 AM PDT – 09:20 AM PDT
    
    • Brad H. Rovin, MD, FASN
  • Treating ANCA-Associated Vasculitis
    09:20 AM PDT – 09:55 AM PDT
    
    • Rachel B. Jones, MD, MBBS
  • Break
    09:55 AM PDT – 10:10 AM PDT
    
  • Clinicopathologic Conference 1: Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy
    10:10 AM PDT – 10:55 AM PDT
    
    • Elaine S. Kamil, MD
    • Cynthia C. Nast, MD, FASN
  • Genetic Testing for Glomerular Diseases: When Do We Need It?
    10:55 AM PDT – 11:30 AM PDT
    
    • Simone Sanna-Cherchi, MD
  • Clinicopathologic Conference 2: Podocytopathies
    11:30 AM PDT – 12:15 PM PDT
    
    • J. Ashley Jefferson, MD, FASN
    • Cynthia C. Nast, MD, FASN
  • Lunch (on your own)
    12:15 PM PDT – 01:15 PM PDT
    
  • Maximizing Supportive Care for Diabetic Kidney Disease and Non-diabetic CKD
    01:15 PM PDT – 01:50 PM PDT
    
    • Sylvia E. Rosas, MD, MS, FASN
  • Balancing Cost and Efficacy of New GN Drugs
    01:50 PM PDT – 02:25 PM PDT
    
    • Sean Barbour, MD, MS, MSc
  • Understanding and Managing Monoclonal Gammopathy of Renal Significance Spectrum Diseases
    02:25 PM PDT – 03:00 PM PDT
    
    • Nelson Leung, MD
  • Break
    03:00 PM PDT – 03:15 PM PDT
    
  • Chimeric Antigen Receptor T Cell Therapy for Glomerular Diseases
    03:15 PM PDT – 03:50 PM PDT
    
    • A. Richard Kitching, MBChB, PhD, FASN
  • Moving the Glomerular Disease Field Forward with Precision Medicine and Clinical Trials
    03:50 PM PDT – 04:25 PM PDT
    
    • Laura H. Mariani, MD, MS, FASN
  • Clinicopathologic Conference 3: Membranous Nephropathy, Infection-Related Glomerulonephritis, and Anti-glomerular Basement Membrane Disease
    04:25 PM PDT – 06:00 PM PDT
    
    • Rupali S. Avasare, MD
    • Glen S. Markowitz, MD